> ## Content Index
> Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# NCPA and CMS preview the next Part D contract-terms rulemaking
- URL: https://members.americanhealthintel.com/2026-09-12-serviceline/
- Published: 2026-09-12T21:01:15.000Z
- Updated: 2026-09-12T21:01:15.000Z
- Description: Plus: Omnicare's confirmation hearing is Sept 17, last step before settlement closes. The day's rules, money, and enforcement, sourced and tiered below.
- Author: American Health Intel

Plus: Omnicare's confirmation hearing is Sept 17, last step before settlement closes. The day's rules, money, and enforcement, sourced and tiered below.

| American Health Intel Rules · Money · Medicine · Decoded daily The Service Line Saturday, September 12, 2026 NCPA and CMS preview the next Part D contract-terms rulemaking Plus: Omnicare's confirmation hearing is Sept 17, last step before settlement closes. The day's rules, money, and enforcement, sourced and tiered below. ![](https://americanhealthintel.com/email/pulse-divider.png) Record The Medicare middlemen fight, called PBM reform, has entered its next round: independent pharmacies and CMS just previewed the rules for what counts as a fair Part D pharmacy contract. The Pharmacy Coalition met CMS this week; a formal request for input is coming next. New contract standards would apply to 2028 plan year deals, effective January 1, 2029. Record CVS Health's long term care pharmacy business, the one that fills prescriptions for nursing home residents nationwide, is one court hearing away from closing its fraud case. Creditors' vote on Omnicare's bankruptcy plan closed Sept 11\. The confirmation hearing is Sept 17, the last step before the $440M DOJ settlement and GenieRx sale can close. Also today Abarca and LucyRx complete their merger, creating a 9M-member independent PBM [Read](https://americanhealthintel.com/editions/2026-09-12-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#abarca-lucyrx-merger-completed) Medicare's GLP-1 Bridge program has been live since July 1 with no published uptake data [Read](https://americanhealthintel.com/editions/2026-09-12-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#medicare-glp1-bridge-program) Independent pharmacies fell by a net 24 nationally in 13 months, not "one a day" [Read](https://americanhealthintel.com/editions/2026-09-12-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#independent-pharmacy-net-closures-2025-digest) 714Records$38.5BEnforcement32Deadlines186Rules [Read this issue + the trackers](https://americanhealthintel.com/editions/2026-09-12-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) Pick your field on the site and every story tells you what it means for you. Reply to this email and tell us what you want covered. We read everything. We show our work. We score our own calls. [Track record](https://americanhealthintel.com/ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Calendar](https://americanhealthintel.com/calendar/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Enforcement](https://americanhealthintel.com/enforcement/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [X](https://x.com/amhealthintel?ref=members.americanhealthintel.com) · [LinkedIn](https://www.linkedin.com/company/american-health-intel?ref=members.americanhealthintel.com) News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) |
| --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |